alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria
about
Role of CD1d-restricted NKT cells in microbial immunityThe Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell GenerationA glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primatesActivation of invariant NKT cells exacerbates experimental visceral leishmaniasisRelationships between Th1 or Th2 iNKT cell activity and structures of CD1d-antigen complexes: meta-analysis of CD1d-glycolipids dynamics simulationsProtective immunity to liver-stage malariaPlasmodium cellular effector mechanisms and the hepatic microenvironmentAutoreactivity by design: innate B and T lymphocytesInvariant NKT cells sustain specific B cell responses and memory.NK cell-like behavior of Valpha14i NK T cells during MCMV infection.Natural killer T cells activated by a lipopeptidophosphoglycan from Entamoeba histolytica are critically important to control amebic liver abscessEnhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.A multifactorial mechanism in the superior antimalarial activity of alpha-C-GalCer.Distinct requirements for CD1d intracellular transport for development of V(alpha)14 iNKT cells.A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-α and MIP1-β, a lack of IL-17, and a Th1-bias in malesInvariant Valpha14 chain NKT cells promote Plasmodium berghei circumsporozoite protein-specific gamma interferon- and tumor necrosis factor alpha-producing CD8+ T cells in the liver after poxvirus vaccination of mice.Hepatitis C virus infection may lead to slower emergence of P. falciparum in bloodThe stimulating adventure of KRN 7000.Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus.Alpha-galactosylceramide promotes killing of Listeria monocytogenes within the macrophage phagosome through invariant NKT-cell activationInterleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice.Inhibition of glycolipid shedding rescues recognition of a CD1+ T cell lymphoma by natural killer T (NKT) cells.During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface proteinAlpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection.Activation of NKT cells protects mice from tuberculosis.Induced pluripotency as a potential path towards iNKT cell-mediated cancer immunotherapy.Progress toward a malaria vaccine: efficient induction of protective anti-malaria immunity.CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infectionGlycolipid targets of CD1-mediated T-cell responses.Liver-inherent immune system: its role in blood-stage malaria.Peripheral blood invariant natural killer T cells of pig-tailed macaquesActivation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cellsActivation of natural killer T cells by alpha-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi.Understanding the function of CD1-restricted T cells.Primary infection of C57BL/6 mice with Plasmodium yoelii induces a heterogeneous response of NKT cells.Genetic control of NKT cell numbers.CD1d-restricted T-cell subsets and dendritic cell function in autoimmunity.NKT cells and viral immunity.Biosynthesis and immunogenicity of glucosylceramide in Cryptococcus neoformans and other human pathogens.Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia
P2860
Q24294851-92B07CEE-023F-4FE6-A682-26B52C231637Q26797344-30023E9E-1D4C-4F16-8074-79EBE73810B3Q27303293-F7D64626-91E2-4DF9-827D-D94514160F01Q27318814-80E42CA3-38D0-42AD-8A30-CD5F47914514Q27320844-DBF74BA4-DCF2-4759-8485-0F3FF4FEF629Q28068626-568019B4-6866-4669-826C-F3A4FBB07F07Q28081143-451B5779-827D-4A13-A95C-F5A553E0272FQ28208367-24991D97-4355-49F5-A1BC-1C4897B67176Q30479030-49E873F2-3C19-4B14-9C0A-950393BC5557Q33352690-DEC08D32-E414-46DC-9CA8-9E7C3D442F3FQ33444653-7BCBBE4E-7843-4724-90E1-4D41A8E58C71Q33552034-C18FF213-68D7-4133-930D-80BBFA6F4025Q33570532-A8171824-7C8F-4FA1-B1B8-2E794C5538F5Q33731430-C65731A6-97EF-4056-ADD6-343C6CF780DAQ33748552-33C0697D-0B03-477A-93E1-71A5270B9367Q33792633-855A5912-2BD2-462A-B8CE-26B88EDEEB63Q33798041-DD05E734-DBED-444E-BF54-006FBBA607D6Q33843406-DB498476-5486-462A-AA1E-EA31598E3C76Q33848840-23CE6414-A775-43B0-87E4-F183C66D66AAQ33877217-C1390CAB-6B6A-4488-B7EC-2DD9BDA34F31Q34006411-05B29BD8-C483-44B7-A203-929EE119C5A5Q34031887-139CB2AD-FB28-440E-B23F-CE2F0496325FQ34115997-424DE480-D037-4A52-B6C7-84FD82B07424Q34172161-712AA78D-879C-4267-B174-1B7A7DC4A49EQ34182581-DB8C5161-7D16-469B-AC0A-F713C5CF8E82Q34275397-1E806221-4CE9-4A1E-90FA-8FA1216AD5A8Q34280935-87AC4527-A5B9-469C-A60F-9ED8A114DD3DQ34402230-222432E0-117F-4AEF-9F27-1C74D54D25D9Q34448496-26B438E7-6A24-4713-88B8-EAE478FED9BFQ34449017-AFF23C40-E94D-4766-BAF2-498E115E0128Q34461021-7446124D-52E6-4921-A47D-5AC30708A6F8Q34467874-6952E94C-AE93-460C-874A-4436849D7D51Q34714252-A88F05ED-1ECA-4466-BBA9-51294ED093A2Q35139857-470B107F-2EA5-4D74-B548-4EA85DE6C39CQ35784187-6736757C-4ED5-4B97-BA21-336AB917640AQ35798141-1C641543-DA9E-4C0A-A65F-C81C43A910B3Q35798159-7B9F5236-5805-43A6-9329-4747775D2E6CQ35798179-066A1E12-9D0C-45EC-B2A0-55FC8DC367FBQ36095320-E35D65EC-BF48-44A5-816F-989D4E8BBB45Q36097274-08DF4F74-BF49-4D7B-8649-36C187786D01
P2860
alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
alpha -galactosylceramide-acti ...... tection against murine malaria
@en
alpha -galactosylceramide-acti ...... ection against murine malaria.
@nl
type
label
alpha -galactosylceramide-acti ...... tection against murine malaria
@en
alpha -galactosylceramide-acti ...... ection against murine malaria.
@nl
prefLabel
alpha -galactosylceramide-acti ...... tection against murine malaria
@en
alpha -galactosylceramide-acti ...... ection against murine malaria.
@nl
P2093
P2860
P50
P356
P1476
alpha -galactosylceramide-acti ...... tection against murine malaria
@en
P2093
A Bendelac
G Gonzalez-Aseguinolaza
L Van Kaer
M Taniguchi
P2860
P304
P356
10.1073/PNAS.97.15.8461
P407
P577
2000-07-01T00:00:00Z